Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report

A patient with lung cancer was administrated osimertinib. She developed symptomatic heart failure due to Takotsubo cardiomyopathy (TC). As her condition improved after discontinuing osimertinib, TC was thought to be caused by osimertinib. Reoccurrence of TC was seen after readministrating half dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Yuko, Kawa, Yoshitaka, Nonaka, Akiko, Shiotani, Hideyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440339/
https://www.ncbi.nlm.nih.gov/pubmed/36093451
http://dx.doi.org/10.1002/ccr3.6279
_version_ 1784782323786448896
author Fukuda, Yuko
Kawa, Yoshitaka
Nonaka, Akiko
Shiotani, Hideyuki
author_facet Fukuda, Yuko
Kawa, Yoshitaka
Nonaka, Akiko
Shiotani, Hideyuki
author_sort Fukuda, Yuko
collection PubMed
description A patient with lung cancer was administrated osimertinib. She developed symptomatic heart failure due to Takotsubo cardiomyopathy (TC). As her condition improved after discontinuing osimertinib, TC was thought to be caused by osimertinib. Reoccurrence of TC was seen after readministrating half dose of osimertinib.[Image: see text]
format Online
Article
Text
id pubmed-9440339
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94403392022-09-09 Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report Fukuda, Yuko Kawa, Yoshitaka Nonaka, Akiko Shiotani, Hideyuki Clin Case Rep Case Report A patient with lung cancer was administrated osimertinib. She developed symptomatic heart failure due to Takotsubo cardiomyopathy (TC). As her condition improved after discontinuing osimertinib, TC was thought to be caused by osimertinib. Reoccurrence of TC was seen after readministrating half dose of osimertinib.[Image: see text] John Wiley and Sons Inc. 2022-09-02 /pmc/articles/PMC9440339/ /pubmed/36093451 http://dx.doi.org/10.1002/ccr3.6279 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Fukuda, Yuko
Kawa, Yoshitaka
Nonaka, Akiko
Shiotani, Hideyuki
Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report
title Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report
title_full Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report
title_fullStr Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report
title_full_unstemmed Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report
title_short Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report
title_sort reoccurrence of takotsubo cardiomyopathy induced by osimertinib: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440339/
https://www.ncbi.nlm.nih.gov/pubmed/36093451
http://dx.doi.org/10.1002/ccr3.6279
work_keys_str_mv AT fukudayuko reoccurrenceoftakotsubocardiomyopathyinducedbyosimertinibacasereport
AT kawayoshitaka reoccurrenceoftakotsubocardiomyopathyinducedbyosimertinibacasereport
AT nonakaakiko reoccurrenceoftakotsubocardiomyopathyinducedbyosimertinibacasereport
AT shiotanihideyuki reoccurrenceoftakotsubocardiomyopathyinducedbyosimertinibacasereport

Ejemplares similares